文献速递肿瘤 PET/CT核素与放射性配体治疗

18F-Florbetaben PET检测多发性骨髓瘤相关淀粉样变性的临床价值:前瞻性病例对照研究

Clinical Utility of 18F-Florbetaben PET for Detecting Amyloidosis Associated With Multiple Myeloma: A Prospective Case-Control Study.
PubMed 文献 · Clin Nucl Med · 2019-01-01

结果显示所有淀粉样变性患者均出现异常摄取,心脏、胃和舌的视觉检出率为100%,肾脏为50%,食管、肝脏和结肠为0%。SUVmax、SUVmean和SUVratio诊断性能无显著差异。

要点

  • 18F-Florbetaben PET/CT可准确检测多发性骨髓瘤患者的全身淀粉样沉积。
  • 心脏、胃和舌的视觉检出率为100%,肾脏为50%,食管、肝脏和结肠为0%。
  • SUVmax、SUVmean和SUVratio的诊断性能无显著差异。

核心结论

  • 18F-Florbetaben PET/CT能准确检测多发性骨髓瘤患者的全身淀粉样沉积,尤其对心脏、胃和舌有用,但对食管、肝脏和结肠价值有限。

主要发现

  • 所有淀粉样变性患者均出现异常示踪剂摄取,视觉检出率在心脏、胃和舌为100%,肾脏为50%,食管、肝脏和结肠为0%。
  • 18F-Florbetaben PET/CT识别出13例意外异常摄取,进一步确认淀粉样沉积。
  • 球形和手动感兴趣区在评估靶器官淀粉样变性时诊断性能相似。
  • SUVmax、SUVmean和SUVratio之间诊断性能无显著差异。

关键数值与推荐

  • 淀粉样沉积根据国际共识指南确认。

临床怎么用

  • 18F-Florbetaben PET/CT可提供器官受累的临床信息,未来可能替代病理检查用于淀粉样变性诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aims of this study were to evaluate the diagnostic performance of F-florbetaben PET/CT for detecting amyloid deposits in patients with multiple myeloma (MM) and to identify the optimal PET analysis method. METHODS: Fourteen patients with MM were prospectively enrolled (6 with amyloidosis, 8 control subjects). Dynamic imaging of the kidneys was performed for 20 minutes, and the retention ratio was obtained. At 90 minutes after injection, PET was performed. All images were assessed qualitatively and quantitatively, and the SUVmax, SUVmean, and SUVratio were obtained. Variables were compared between the amyloidosis group and the control group. Amyloid deposition was confirmed according to international consensus guidelines. RESULTS: Tracer uptake was abnormal in all patients with amyloidosis. The visual detection rate was excellent (100%) in the heart, stomach, and tongue but limited in the kidneys (50%) and poor (0%) in the esophagus, liver, and colon. F-florbetaben PET/CT identified 13 unexpected cases of abnormal uptake, confirming further amyloid deposition. Both spherical and manual volumes of interest showed similar diagnostic performance when evaluating amyloidosis in target organs. There was no significant difference in diagnostic performance between the SUVmax, SUVmean, and SUVratio. CONCLUSIONS: F-florbetaben PET/CT can accurately detect systemic amyloid deposits in patients with MM. F-florbetaben PET/CT was particularly useful in the heart, stomach, and tongue but of limited value in the esophagus, liver, and colon. F-florbetaben PET/CT can provide clinical information on organ involvement and could replace pathologic examination for diagnosis of amyloidosis in the future.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Seo M, Cha HJ, Kim M, et al. Clinical Utility of 18F-Florbetaben PET for Detecting Amyloidosis Associated With Multiple Myeloma: A Prospective Case-Control Study. Clin Nucl Med. 2019. PMID: 31283608. doi:10.1097/RLU.0000000000002699

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。